Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Comparing two surgical techniques for ACL reconstruction

Official title: A Single-center, Patient-blinded, Randomized, 2-year, Parallel-group, Superiority Study to Compare the Efficacy of Augmented ACL Integration Via Platelet-rich-plasma Enriched Collected Autologous Bone Versus Standard ACL Technique

Run by Schulthess Klinik · NCT05953051 · Data updated 2026-11-12

This study is testing if using a special material made of bone and platelet-rich plasma during ACL surgery can help people recover better and have fewer problems with their knees compared to standard surgery.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment107 (estimated)
SponsorSchulthess Klinik
Academic / other
Locations1 site (Zurich)
StatusRecruiting
StartedJanuary 2024
Main results expectedAugust 2026
Study endsAugust 2027
Registry record updatedJanuary 29, 2024
Trial IDNCT05953051 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-50 with a primary ACL rupture occurring within 4 weeks to 6 months prior to surgery.

Probably not a fit

Patients with concomitant ligamentous injuries, significant osteoarthritis, or those requiring invasive cartilage treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study aims to compare the outcomes of two surgical techniques for anterior cruciate ligament (ACL) reconstruction after a primary ACL tear. Participants will be randomly assigned to either an experimental group receiving a bone and platelet-rich plasma (PrP) composite material or a control group undergoing standard ACL reconstruction. The study will assess tibial tunnel widening and graft incorporation using CT and MRI scans, along with functional knee testing and patient-reported outcomes over a 24-month follow-up period. The goal is to determine if the composite material can reduce tunnel widening and improve graft integration.

Why it matters

Potential benefit: If successful, this approach could lead to improved outcomes and reduced complications for patients undergoing ACL reconstruction.

How similar studies have gone: While similar approaches have been explored, this specific combination of techniques is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-50 years
* Primary ACL rupture
* Time from injury to surgery: 4 weeks to 6 months
* Single ACL rupture (isolated rupture)
* ACL surgery with one of the participating senior surgeons
* Informed Consent as documented by signature

Exclusion Criteria:

* Concomitant ligamentous instability/rupture
* Requirement for Meniscus suture (partial resection accepted, hoop and roots remain intact)
* Requirement for cartilage invasive treatment (debridement accepted)
* Osteoarthritis at index knee joint
* Leg axis deviation over 3° valgus or 4° varus
* Claustrophobia (contra-indication for the MRI)
* Women who are pregnant or breast feeding or intention to become pregnant during the study
* Known or suspected non-compliance, drug or alcohol abuse
* Inability of the patient to follow the study procedures, e.g. language problems, psychological disorders, dementia, etc.

Where it's running

  • Schulthess Klinik
    Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.